Mirai Medical Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $7.85M

  • Investors
  • 10

Mirai Medical General Information

Description

Developer of a pulsed electric field-based therapeutic platform designed to treat gastrointestinal diseases through endoscopic intervention. The company's platform offers ultra-short electrical pulse technology that permeabilizes diseased cell membranes without damaging surrounding tissue, enabling gastroenterologists and surgical teams to treat gastrointestinal tumours in outpatient and surgical settings with reduced impact on healthy structures.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 5, Howley Court
  • Oranmore
  • Galway H91 FK6C
  • Ireland
Primary Industry
Outcome Management (Healthcare)
Other Industries
Other Devices and Supplies
Therapeutic Devices
Corporate Office
  • Unit 5, Howley Court
  • Oranmore
  • Galway H91 FK6C
  • Ireland

Mirai Medical Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mirai Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 31-Dec-2023 $7.85M Completed Generating Revenue
5. Accelerator/Incubator 17-Nov-2023 Completed Generating Revenue
4. Early Stage VC 06-Jan-2021 Completed Generating Revenue
3. Early Stage VC 13-Nov-2019 Completed Generating Revenue
2. Early Stage VC 28-Apr-2019 $2.02M $3.33M Completed Generating Revenue
1. Early Stage VC 18-Jun-2018 $1.31M $1.31M Completed Generating Revenue
To view Mirai Medical’s complete valuation and funding history, request access »

Mirai Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
8% CRCP
Ordinary
Ordinary
Ordinary
Ordinary 283 $1.091795 $96.45 $96.45 1x $96.45 0.94%
Ordinary 268 $1.091795 $101.84 $101.84 1x $101.84 0.89%
To view Mirai Medical’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Mirai Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a pulsed electric field-based therapeutic platform designed to treat gastrointestinal diseases through endo
Outcome Management (Healthcare)
Galway, Ireland
18 As of 2025

Pleasanton, CA
 

Plymouth, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mirai Medical Competitors (6)

One of Mirai Medical’s 6 competitors is Aqua Medical, a Venture Capital-Backed company based in Pleasanton, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aqua Medical Venture Capital-Backed Pleasanton, CA
Endogenex Venture Capital-Backed Plymouth, MN
Pulse Biosciences Corporation Hayward, CA
Angiodynamics Corporation Latham, NY
Neem's Hill Corporation Lund, Sweden
To view Mirai Medical’s complete competitors history, request access »

Mirai Medical Patents

Mirai Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026099486-A1 Devices for delivery of electric pulses to treat various conditions Pending 11-Nov-2024
US-20260232999-A1 A method and apparatus for electroporation Pending 12-May-2023
WO-2024235826-A1 A method and apparatus for electroporation Inactive 12-May-2023
EP-4709468-A1 Method and apparatus for electroporation Pending 12-May-2023
EP-4580533-A1 An electroporation probe and apparatus Pending 02-Sep-2022 A61B18/1477
To view Mirai Medical’s complete patent history, request access »

Mirai Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mirai Medical Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
DeepIE Ventures Venture Capital Minority
MedTech Innovator Accelerator/Incubator
Boole Nominees Venture Capital Minority
EAF Irish Angel Nominees 15 Angel Group Minority
Irrus Investments Angel Group Minority
You’re viewing 5 of 10 investors. Get the full list »

Mirai Medical FAQs

  • When was Mirai Medical founded?

    Mirai Medical was founded in 2018.

  • Where is Mirai Medical headquartered?

    Mirai Medical is headquartered in Galway, Ireland.

  • What is the size of Mirai Medical?

    Mirai Medical has 18 total employees.

  • What industry is Mirai Medical in?

    Mirai Medical’s primary industry is Outcome Management (Healthcare).

  • Is Mirai Medical a private or public company?

    Mirai Medical is a Private company.

  • What is the current valuation of Mirai Medical?

    The current valuation of Mirai Medical is .

  • What is Mirai Medical’s current revenue?

    The current revenue for Mirai Medical is .

  • How much funding has Mirai Medical raised over time?

    Mirai Medical has raised $15.6M.

  • Who are Mirai Medical’s investors?

    DeepIE Ventures, MedTech Innovator, Boole Nominees, EAF Irish Angel Nominees 15, and Irrus Investments are 5 of 10 investors who have invested in Mirai Medical.

  • Who are Mirai Medical’s competitors?

    Aqua Medical, Endogenex, Pulse Biosciences, Angiodynamics, and Neem's Hill are some of the 6 competitors of Mirai Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process